MG

Michael Gruber

Managing Partner, Salveo Capital.

📍 Northbrook, Illinois, United States🔄 Updated September 2026💼 6 investments📅 31 years investing🗓 Last invested Nov 2021
VC🌍 United States
6
Total investments
1
Early stage
1
Mid stage
0
Late stage
31y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Nov 2021
BlockFills is a technology and crypto trading firm in the digital assets space. BlockFills has created a trading ecosystem that combines world-class liquidity and professional trading connectivity with secure settlements.
Board Observer
Jan 2017
Plant growers are hamstrung by three major problems: expense, risk and safety, and a lack of innovation. The scientific tools of modern agriculture developed in the last 40 years have increased the profit, safety, and rate of innovation for the crops consumed daily worldwide. These tools include tissue culturing, genetic assays, and marker assisted breeding. Front Range Biosciences enables a grower to reduce crop loss due to pathogens, quickly sex a plant, and develop new strains of plants that have the most valuable commercial properties. We increase a grower's profit, reduce its risk, and give it new products. We have the right team of PhD bioscientists, MIT MBAs, DuPont plant experts, and seasoned biotechnology entrepreneurs. We have the right market, little professional competition, and the right product-market fit. Front Range Biosciences is a vertically integrated biotech company with a strong IP portfolio and licensing strategy. We are excited to usher a new era in modern plant breeding and growing.
Investor, Mentor
May 2013
Techstars Chicago is at the center of the Midwest startup community, one of the fastest growing ecosystems in the U.S. Follow @techstars for more.
Experience · 17 entries
All (17)
Investments (6)
Founder (4)
Board (1)
2022
Co-Founder & Chief Strategy Officer
Feb 2022
Pura Industries is a state-of-the-art, fully integrated cannabis company founded to establish the standards for “artisan agriculture” and the purest, highest quality organic cannabis available anywhere. We are driven by an obsessive quest for purity, potency, and a commitment to consistently deliver ultra-pure, ultra-premium quality products and results throughout the business — from seed to sale Pura Industries operates in California, New Jersey, and New York.
2021
Investor
Nov 2021
BlockFills is a technology and crypto trading firm in the digital assets space. BlockFills has created a trading ecosystem that combines world-class liquidity and professional trading connectivity with secure settlements.
Managing Partner
Feb 2021
JLS is an NY-based venture capital fund formed to invest in the exciting intersection of science, technology and neurology, leveraging the enormous potential of plant-based and psychedelic medicines to heal illness and enhance wellness. They focus on the development of drugs for intractable mental and physical conditions and the enabling technology and tools that can accelerate and enhance the delivery of those therapies.
2017
Board Observer
Jan 2017
Plant growers are hamstrung by three major problems: expense, risk and safety, and a lack of innovation. The scientific tools of modern agriculture developed in the last 40 years have increased the profit, safety, and rate of innovation for the crops consumed daily worldwide. These tools include tissue culturing, genetic assays, and marker assisted breeding. Front Range Biosciences enables a grower to reduce crop loss due to pathogens, quickly sex a plant, and develop new strains of plants that have the most valuable commercial properties. We increase a grower's profit, reduce its risk, and give it new products. We have the right team of PhD bioscientists, MIT MBAs, DuPont plant experts, and seasoned biotechnology entrepreneurs. We have the right market, little professional competition, and the right product-market fit. Front Range Biosciences is a vertically integrated biotech company with a strong IP portfolio and licensing strategy. We are excited to usher a new era in modern plant breeding and growing.
2016
Managing Partner
Jul 2016
Salveo Capital’s investment objective is to achieve long term capital appreciation by investing in high-growth companies servicing the cannabis space. The fund has brought together a highly experienced management team that has managed multiple private equity funds, and have built and managed early stage companies from early beginnings through exits. Salveo Capital is dedicated to shaping this burgeoning industry by providing funding and strong strategic support.
Show all 17 entries ↓
Investment activity
1995–2021 · 6 investments
1995120132201612017120211
Recent (last 2 years)Earlier